Home/Filings/4/0001209191-22-043290
4//SEC Filing

Al-Wakeel Yasir B. 4

Accession 0001209191-22-043290

CIK 0001741830other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 6:22 PM ET

Size

7.0 KB

Accession

0001209191-22-043290

Insider Transaction Report

Form 4
Period: 2022-07-25
Al-Wakeel Yasir B.
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-07-25+40,00040,000 total
    Exercise: $5.02Exp: 2032-07-24Common Stock (40,000 underlying)
  • Award

    Common Stock

    2022-07-25+53,600216,841 total
Footnotes (1)
  • [F1]50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023.

Issuer

Kronos Bio, Inc.

CIK 0001741830

Entity typeother

Related Parties

1
  • filerCIK 0001650691

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 6:22 PM ET
Size
7.0 KB